Self-Care Training for Family Caregivers of Persons With Neurodegeneration
Caring for the Family Caregiver: Testing the Effect of Two Wellness Programs That Support the Well-being of Family Caregivers of Persons With Neurodegenerative Disorders
Toronto Metropolitan University
232 participants
Jun 1, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess whether an 8-week mindfulness program enhances psychological well-being (e.g., stress, depressive symptoms), biological indicators of stress (e.g., inflammation), and cognitive function (e.g., attentional ability) in primary family caregivers of persons with dementia or a related neurodegenerative disease. A total of 232 primary family caregivers aged 50+ years of age will be recruited for this study and randomized to one of three groups: mindfulness meditation (MM), psychoeducation (PSY) or caregiver respite (CR). All participants will complete three testing sessions: baseline (pre-intervention \[T1\]), post 8-week follow-up (post-intervention, \[T2\]), and 12-month follow-up (T3).
Eligibility
Inclusion Criteria3
- + years of age
- Currently a primary family caregiver
- Fluent in English
Exclusion Criteria5
- Existing mindfulness practice
- Diagnosed/Presenting with Post-traumatic Stress Disorder; Substance Disorder; Psychosis
- Unable to attend 8 sessions
- No access to a computer or high-speed internet
- Not willing to be randomized
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
8-week mindfulness meditation program, based on Kabat-Zinn's MBSR program and modified for caregivers. The intervention will be led by MBSR-trained facilitators.
A lecture-style program based on the "10 Keys"TM to Healthy Aging Course, an evidence-based program for older adults. The program will be delivered by a facilitator experienced in delivering similar content.
Participants will receive two hours of respite from their caregiving responsibilities per week, for eight weeks. They will be given the opportunity to participate in either the MM or the PSY condition following completion of testing.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06200909